Cover Image
市場調查報告書

全球超級崩散劑市場預測 ∼2021年:交聯羧甲基纖維素鈉、Crospovidone、羧甲基澱粉鈉、離子交換樹脂

Superdisintegrants Market by Product (Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resins), Application (Tablets, Capsules), Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 359268
出版日期 內容資訊 英文 176 Pages
訂單完成後即時交付
價格
Back to Top
全球超級崩散劑市場預測 ∼2021年:交聯羧甲基纖維素鈉、Crospovidone、羧甲基澱粉鈉、離子交換樹脂 Superdisintegrants Market by Product (Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resins), Application (Tablets, Capsules), Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases) - Global Forecast to 2021
出版日期: 2016年06月01日 內容資訊: 英文 176 Pages
簡介

全球超級崩散劑的市場預計從2016年到2021年以7.8%的年複合成長率發展,從2016年的2億8680萬美元,成長到2021年的4億1650萬美元的規模。學名藥市場成長,老年人口和兒童患者數的增加,醫藥品取向的新超級崩散劑的崛起等要素,促進該市場的成長。

本報告提供全球超級崩散劑的市場調查,市場及產品概要,產業結構與價值鏈,影響市場成長因素及市場機會分析,各產品、用途、對象疾病、地區/主要國家趨勢與市場規模變化與預測,競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 亞太地區的各產品市場成果
  • 地區概要
  • 地區結構
  • 先進國家市場 vs 新興國家市場

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推進因素
    • 阻礙要素
    • 市場機會
    • 課題

第6章 產業趨勢

  • 簡介
  • 產業趨勢
  • 法律規章分析:各地區
  • 波特的五力分析

第7章 市場分析:各產品類型

  • 簡介
  • 天然來源
  • 合成劑
    • 化工澱粉 (羧甲基澱粉鈉)
    • 加工纖維素
    • Crospovidone
    • 離子交換樹脂
    • 硅酸鈣
  • 其他

第8章 市場分析:各用途

  • 簡介
  • 平板電腦
  • 膠囊

第9章 市場分析:各疾病種類

  • 簡介
  • 消化器官系統疾病
  • 神經疾病
  • 癌症
  • 感染疾病
  • 心血管疾病
  • 血液疾病
  • 發炎性疾病

第10章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 瑞士
    • 德國
    • 義大利
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 其他
  • 其他地區
    • 南美
    • 中東、非洲

第11章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
    • 擴張
    • 新產品的投入
    • 收購
    • 聯盟
    • 其他

第12章 企業簡介

  • 簡介
  • ASHLAND INC.
  • BASF SE
  • FMC CORPORATION
  • DFE PHARMA
  • JRS PHARMA
  • ROQUETTE
  • THE DOW CHEMICAL COMPANY
  • 旭化成
  • 日本曹達
  • HUBER CORPORATION
    • 概要
    • 財務趨勢
    • 產品與服務
    • 策略
    • 發展趨勢等

第13章 附錄

目錄
Product Code: PH 4350

The global superdisintegrants market is expected to grow at a CAGR of 7.8% during the forecast period from 2016 to 2021. The market is poised to reach USD 416.5 million by 2021 from USD 286.8 million in 2016. The market is primarily driven by growing generic drugs market, growing population of geriatric and paediatric patients, and emergence of new superdisintegrants for the pharmaceutical industry.

In this report, the superdisintegrants market is segmented on the basis of product type, application, therapeutic area, and geography. On the basis of product type, the market is primarily segmented into natural superdisintegrants, synthetic superdisintegrants, and others. The synthetic superdisintegrants market is further sub-segmented into modified starch, crospovidone, modified cellulose, ion exchange resins, and calcium silicates. The modified cellulose market on the other hand is sub-segmented into croscarmellose sodium and L-HPC. On the basis of application the market is segmented into tablets and capsules. The market by therapeutic area is segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, cardiovascular diseases, haematological diseases, and inflammatory diseases.

In 2015, the synthetic superdisintegrants market accounted for the largest share of the superdisintegrants market. The large share of this segment is majorly attributed to widespread use of excipients such as sodium starch glycolate, and crospovidone in orally and fast disintegrating tablets. The crospovidone market is expected to grow at the highest CAGR during the forecast period, due to the rising preference of the excipient in formulations of solid oral dosage forms.

In 2015, North America accounted for the largest share of the global superdisintegrants market, followed by Europe, Asia-Pacific, and Rest of the World. Asia-Pacific is expected to be the fastest-growing region during the forecast period, due to the increasing outsourcing of excipient manufacturing to Asian countries, such as India and China.

Some key players in this market include Ashland, Inc. (U.S.), BASF SE (Germany), FMC Corporation (U.S.), JRS Pharma (Germany), DFE Pharma (Germany), Roquette (France), The Dow Chemical Company (U.S.), Asahi Kasei Corporation (Japan), Nippon Soda Co., Ltd. (Japan), and Huber Corporation (U.S.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below-mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by top players in the superdisintegrants market. The report analyzes the superdisintegrants market by product type, application, therapeutic area, and region
  • Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the superdisintegrants market
  • Market Development: Comprehensive information about lucrative emerging markets by product and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the superdisintegrants market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and manufacturing capabilities of leading players in the superdisintegrants market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. SUPERDISINTEGRANTS MARKET OVERVIEW
  • 4.2. ASIA-PACIFIC: SUPERDISINTEGRANTS MARKET, BY PRODUCT (2015)
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE SUPERDISINTEGRANTS MARKET
  • 4.4. REGIONAL MIX OF THE SUPERDISINTEGRANTS MARKET
  • 4.5. SUPERDISINTEGRANTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY PRODUCT
    • 5.2.2. BY APPLICATION
    • 5.2.3. BY THERAPEUTIC AREA
  • 5.3. KEY MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Growing generics market
      • 5.3.1.2. Growing population of geriatric and pediatric patients
      • 5.3.1.3. Emergence of new superdisintegrants for the pharmaceutical industry
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Declining R&D investments in superdisintegrants development
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Market expansion in emerging countries
      • 5.3.3.2. Rising healthcare expenditure
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Quality concerns demanding greater transparency in supply chain
      • 5.3.4.2. Formulation of palatable ODTs

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. INDUSTRY TRENDS
    • 6.2.1. GROWING NUTRACEUTICALS MARKET DRIVING THE DEMAND FOR SUPERDISINTEGRANTS
    • 6.2.2. RISING FOCUS OF THE PHARMACEUTICAL INDUSTRY ON ORALLY DISINTEGRATING TABLETS
  • 6.3. REGULATORY ANALYSIS
    • 6.3.1. NORTH AMERICA:
      • 6.3.1.1. U.S.
      • 6.3.1.2. Canada
    • 6.3.2. EUROPE
    • 6.3.3. APAC
      • 6.3.3.1. Japan
      • 6.3.3.2. China
      • 6.3.3.3. India
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. THREAT OF NEW ENTRANTS
    • 6.4.2. THREAT OF SUBSTITUTES
    • 6.4.3. BARGAINING POWER OF SUPPLIERS
    • 6.4.4. BARGAINING POWER OF BUYERS
    • 6.4.5. INTENSITY OF COMPETITIVE RIVALRY

7. SUPERDISINTEGRANTS MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. NATURAL SUPERDISINTEGRANTS
  • 7.3. SYNTHETIC SUPERDISINTEGRANTS
    • 7.3.1. MODIFIED STARCH (SODIUM STARCH GLYCOLATE)
    • 7.3.2. MODIFIED CELLULOSE
      • 7.3.2.1. Croscarmellose-sodium
      • 7.3.2.2. Low-substituted Hydroxypropyl Cellulose (L-HPC)
    • 7.3.3. CROSPOVIDONE
    • 7.3.4. ION EXCHANGE RESINS
    • 7.3.5. CALCIUM SILICATES
  • 7.4. OTHERS

8. SUPERDISINTEGRANTS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. TABLETS
  • 8.3. CAPSULES

9. SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA

  • 9.1. INTRODUCTION
  • 9.2. GASTROINTESTINAL DISEASES
  • 9.3. NEUROLOGICAL DISEASES
  • 9.4. ONCOLOGY
  • 9.5. INFECTIOUS DISEASES
  • 9.6. CARDIOVASCULAR DISEASES
  • 9.7. HEMATOLOGICAL DISEASES
  • 9.8. INFLAMMATORY DISEASES

10. GEOGRAPHIC ANALYSIS

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. SWITZERLAND
    • 10.3.2. GERMANY
    • 10.3.3. ITALY
    • 10.3.4. FRANCE
    • 10.3.5. U.K.
    • 10.3.6. SPAIN
    • 10.3.7. REST OF EUROPE (ROE)
  • 10.4. ASIA-PACIFIC (APAC)
    • 10.4.1. JAPAN
    • 10.4.2. INDIA
    • 10.4.3. CHINA
    • 10.4.4. REST OF ASIA-PACIFIC (ROAPAC)
  • 10.5. REST OF THE WORLD (ROW)
    • 10.5.1. LATIN AMERICA
    • 10.5.2. MIDDLE EAST AND AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. EXPANSIONS
    • 11.3.2. NEW PRODUCT LAUNCHES
    • 11.3.3. ACQUISITIONS
    • 11.3.4. COLLABORATIONS
    • 11.3.5. OTHERS

12. COMPANY PROFILES (Overview, Financial*, Products & Services, Strategy, and Developments)

  • 12.1. INTRODUCTION
  • 12.2. ASHLAND INC.
  • 12.3. BASF SE
  • 12.4. FMC CORPORATION
  • 12.5. DFE PHARMA
  • 12.6. JRS PHARMA
  • 12.7. ROQUETTE
  • 12.8. THE DOW CHEMICAL COMPANY
  • 12.9. ASAHI KASEI CORPORATION
  • 12.10. NIPPON SODA CO., LTD.
  • 12.11. HUBER CORPORATION

*Details might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. OTHER DEVELOPMENTS
  • 13.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.6. AVAILABLE CUSTOMIZATIONS
  • 13.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: MARKET DRIVERS: IMPACT ANALYSIS
  • TABLE 2: MARKET RESTRAINTS: IMPACT ANALYSIS
  • TABLE 3: MARKET OPPORTUNITIES: IMPACT ANALYSIS
  • TABLE 4: MARKET CHALLENGES: IMPACT ANALYSIS
  • TABLE 5: GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014 - 2021 (USD MILLION)
  • TABLE 6: GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 7: GLOBAL NATURAL SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: GLOBAL SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: GLOBAL MODIFIED STARCH MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: GLOBAL MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 12: GLOBAL MODIFIED CELLULOSE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL CROSCARMELLOSE-SODIUM MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL L-HPC MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: GLOBAL CROSPOVIDONE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: GLOBAL ION EXCHANGE RESINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL CALCIUM SILICATES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL OTHER SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 19: GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 20: GLOBAL SUPERDISINTEGRANTS MARKET SIZE FOR TABLETS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: GLOBAL SUPERDISINTEGRANTS MARKET SIZE FOR CAPSULES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 23: GLOBAL SUPERDISINTEGRANTS MARKET SIZE FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: GLOBAL SUPERDISINTEGRANTS MARKET SIZE FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2014-2021 (USD MILLION) 77  
  • TABLE 25: GLOBAL SUPERDISINTEGRANTS MARKET SIZE FOR ONCOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL SUPERDISINTEGRANTS MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: GLOBAL SUPERDISINTEGRANTS MARKET SIZE FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: GLOBAL SUPERDISINTEGRANTS MARKET SIZE FOR HEMATOLOGICAL DISEASES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: GLOBAL SUPERDISINTEGRANTS MARKET SIZE FOR INFLAMMATORY DISEASES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: GLOBAL SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: NORTH AMERICA: SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: NORTH AMERICA: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 37: U.S.: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 38: U.S.: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 39: U.S.: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 40: U.S.: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 41: U.S.: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 42: CANADA: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 43: CANADA: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 44: CANADA: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 45: CANADA: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 46: CANADA: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 97  
  • TABLE 49: EUROPE: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 52: EUROPE: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 53: SWITZERLAND: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 54: SWITZERLAND: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: SWITZERLAND: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: SWITZERLAND: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 57: SWITZERLAND: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 58: GERMANY: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 59: GERMANY: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: GERMANY: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: GERMANY: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 62: GERMANY: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 63: ITALY: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 64: ITALY: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: ITALY: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 66: ITALY: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 67: ITALY: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 68: FRANCE: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 69: FRANCE: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: FRANCE: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: FRANCE: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 72: FRANCE: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION) 108  
  • TABLE 73: U.K.: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 74: U.K.: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 75: U.K.: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 76: U.K.: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 77: U.K.: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 78: SPAIN: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 79: SPAIN: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 80: SPAIN: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 81: SPAIN: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 82: SPAIN: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 83: ROE: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 84: ROE: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: ROE: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 86: ROE: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 87: ROE: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 88: APAC: SUPERDISINTEGRANTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 89: APAC: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 90: APAC: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 91: APAC: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 92: APAC: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 93: APAC: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 94: JAPAN: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 95: JAPAN: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: JAPAN: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: JAPAN: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 98: JAPAN: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION) 122  
  • TABLE 99: INDIA: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 100: INDIA: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 101: INDIA: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 102: INDIA: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 103: INDIA: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 104: CHINA: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 105: CHINA: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 106: CHINA: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 107: CHINA: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 108: CHINA: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 109: ROAPAC: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 110: ROAPAC: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 111: ROAPAC: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 112: ROAPAC: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 113: ROAPAC: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 114: ROW: SUPERDISINTEGRANTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 115: ROW: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 116: ROW: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 117: ROW: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 118: ROW: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 119: ROW: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 120: LATIN AMERICA: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 121: LATIN AMERICA: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 122: LATIN AMERICA: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 123: LATIN AMERICA: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 133  
  • TABLE 124: LATIN AMERICA: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 125: MIDDLE EAST AND AFRICA: SUPERDISINTEGRANTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 126: MIDDLE EAST AND AFRICA: SYNTHETIC SUPERDISINTEGRANTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 127: MIDDLE EAST AND AFRICA: MODIFIED CELLULOSE MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 128: MIDDLE EAST AND AFRICA: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 129: MIDDLE EAST AND AFRICA: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 130: GROWTH STRATEGY MATRIX, 2013-2016
  • TABLE 131: EXPANSIONS, 2015 & 2016
  • TABLE 132: NEW PRODUCT LAUNCHES, 2013-2016
  • TABLE 133: ACQUISITIONS, 2015
  • TABLE 134: COLLABORATIONS, 2014
  • TABLE 135: OTHERS, 2015 & 2016

LIST OF FIGURES

  • FIGURE 1: SUPERDISINTEGRANTS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: SUPERIDISINTEGRANTS MARKET SIZE, BY PRODUCT TYPE, 2016 VS. 2021
  • FIGURE 7: SYNTHETIC SUPERIDISINTEGRANTS MARKET SIZE, BY TYPE, 2016 VS. 2021
  • FIGURE 8: SUPERDISINTEGRANTS MARKET SIZE, BY APPLICATION, 2016 VS. 2021
  • FIGURE 9: SUPERDISINTEGRANTS MARKET SIZE, BY THERAPEUTIC AREA, 2016 VS. 2021
  • FIGURE 10: ASIA-PACIFIC REGION TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 11: GROWING GENERICS MARKET AND INCREASING GERIATRIC PATIENT POPULATION TO DRIVE MARKET GROWTH
  • FIGURE 12: SYNTHETIC SUPERDISINTEGRANTS MARKET ACCOUNTED FOR THE MAJOR SHARE OF THE ASIA-PACIFIC SUPERDISINTEGRANTS MARKET
  • FIGURE 13: U.S. COMMANDED THE LARGEST SHARE OF THE SUPERDISINTEGRANTS MARKET IN 2015
  • FIGURE 14: NORTH AMERICA TO DOMINATE THE SUPERDISINTEGRANTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: SUPERDISINTEGRANTS MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 17: SUPERDISINTEGRANTS MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 18: SUPERDISINTEGRANTS MARKET SEGMENTATION, BY THERAPEUTIC AREA
  • FIGURE 19: SUPERDISINTEGRANTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 20: DEMOGRAPHIC GROWTH TRENDS OF THE ELDERLY POPULATION
  • FIGURE 21: MAJOR TRENDS IN THE SUPERDISINTEGRANTS MARKET
  • FIGURE 22: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 23: SYNTHETIC SUPERDISINTEGRANTS DOMINATE THE GLOBAL SUPERDISINTEGRANTS MARKET
  • FIGURE 24: CROSPOVIDONE SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 25: TABLETS SEGMENT TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD (2016-2021)
  • FIGURE 26: NEUROLOGICAL DISEASES SEGMENT EXPECTED TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 27: GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA-PACIFIC ARE EMERGING HOTSPOTS
  • FIGURE 28: SUPERDISINTEGRANTS MARKET, BY REGION, 2015 VS. 2021
  • FIGURE 29: NORTH AMERICA: SUPERDISINTEGRANTS MARKET SNAPSHOT
  • FIGURE 30: EUROPE: SUPERDISINTEGRANTS MARKET SNAPSHOT
  • FIGURE 31: ASIA-PACIFIC: SUPERDISINTEGRANTS MARKET SNAPSHOT
  • FIGURE 32: EXPANSIONS WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS BETWEEN 2013 & 2016
  • FIGURE 33: GLOBAL SUPERDISINTEGRANTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 34: BATTLE FOR MARKET SHARE: EXPANSIONS WAS THE KEY STRATEGY ADOPTED BY PROMINENT PLAYERS IN THE SUPERDISINTEGRANTS MARKET
  • FIGURE 35: GEOGRAPHIC REVENUE MIX OF THE TOP THREE PLAYERS
  • FIGURE 36: COMPANY SNAPSHOT: ASHLAND INC.
  • FIGURE 37: COMPANY SNAPSHOT: BASF SE
  • FIGURE 38: COMPANY SNAPSHOT: FMC CORPORATION
  • FIGURE 39: COMPANY SNAPSHOT: ROQUETTE
  • FIGURE 40: COMPANY SNAPSHOT: THE DOW CHEMICAL COMPANY
  • FIGURE 41: COMPANY SNAPSHOT: ASAHI KASEI CORPORATION
  • FIGURE 42: COMPANY SNAPSHOT: NIPPON SODA CO., LTD.
Back to Top